Prostate Cancer - Results from #19520

Does choline PET/CT change the management of prostate cancer patients with biochemical failure? - Abstract December 10, 2014

Impact of pelvic biometric measurements, visceral and subcutaneous adipose tissue areas on trifecta outcome and surgical margin status after open radical retropubic prostatectomy - Abstract December 10, 2014

Quality indicators for prostate radiotherapy: Are patients disadvantaged by receiving treatment in a 'generalist' centre? - Abstract December 10, 2014

Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity - Abstract December 10, 2014

Searching for an appropriate image-guided radiotherapy method in prostate cancer - implications for safety margin - Abstract December 9, 2014

Penson to lead department of urologic surgery at Vanderbilt University Medical Center December 8, 2014

Cost-effectiveness analysis of abiraterone and sipuleucel-T in asymptomatic metastatic castration-resistant prostate cancer - Abstract December 8, 2014

Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: An early experience - Abstract December 8, 2014

First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection - Abstract December 8, 2014

Prostate cancer prophylaxis by dietary supplements: More than just an illusion? - Abstract December 8, 2014

Rapid Arc, helical tomotherapy, sliding window intensity modulated radiotherapy and three dimensional conformal radiation for localized prostate cancer: A dosimetric comparison - Abstract December 8, 2014

Magnetic resonance imaging-directed transperineal limited-mapping prostatic biopsies to diagnose prostate cancer: A Scottish experience - Abstract December 8, 2014

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: The critical role of the pathologist - Abstract December 8, 2014

Who dies from prostate cancer? - Abstract December 5, 2014

Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: Results from a privately insured patient population - Abstract December 5, 2014

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: Results of a randomized phase II neoadjuvant study - Abstract December 5, 2014

#SUO14 - Session Highlights: Sequencing prior to chemotherapy December 5, 2014

Localised prostate cancer and hemophilia A (AHA): Case report and management of the disease - Abstract December 5, 2014

Models of assessment of comparative outcomes of robot-assisted surgery: Best evidence regarding the superiority or inferiority of robot-assisted radical prostatectomy - Abstract December 5, 2014

The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy - Abstract December 5, 2014

Page 977 of 1451